Transcription Factor II B (TFIIB) activators are a class of molecules known for their ability to enhance the activity or expression of TFIIB. TFIIB is a general transcription factor crucial to the initiation of transcription in eukaryotic cells. By interacting with the TATA-binding protein (TBP), TFIIB plays a significant role in precisely positioning RNA polymerase II on the gene promoter to commence transcription. Therefore, activators of TFIIB can influence this critical stage of gene expression.
TFIIB activators can function through various mechanisms. Some may interact directly with TFIIB, enhancing its ability to bind to TBP and position RNA polymerase II. Others may influence the expression of TFIIB by affecting the transcription or translation processes of the TFIIB gene, thereby increasing the cellular level of TFIIB. Additional compounds might influence upstream or downstream signaling pathways that indirectly modulate TFIIB activity. For example, some TFIIB activators may affect the cellular response to stress or damage, which could, in turn, impact the role of TFIIB in these responses. Regardless of their specific mechanisms of action, all TFIIB activators share the common characteristic of enhancing the activity or expression of TFIIB in some way. These compounds provide a valuable tool for studying the complex process of transcription initiation and the role of TFIIB in this crucial cellular process.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide could potentially modulate TFIIB expression through its action on protein synthesis inhibition. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide might influence TFIIB expression due to its DNA damage inducing properties. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil might modulate TFIIB expression due to its interactions with RNA and DNA metabolism. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine might influence TFIIB expression through its effects on DNA methylation. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin could potentially upregulate TFIIB due to its action on DNA repair mechanisms. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin could potentially induce TFIIB expression as part of its effects on DNA intercalation and topoisomerase II inhibition. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine could potentially induce TFIIB expression due to its potent effects on various kinases. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A might enhance TFIIB expression via its histone deacetylase (HDAC) inhibitory properties. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate could potentially induce TFIIB expression due to its HDAC inhibitory properties. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could potentially upregulate TFIIB through its role in cellular stress response. | ||||||